Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial | Scientific Reports
Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf
Design of the lurasidone open-label core and extension switch studies.*... | Download Scientific Diagram
35 Open Label Study Advantages And Disadvantages - Labels For Your Ideas
32 Open Label Extension Study - Labels For Your Ideas
Flow chart showing the study design of the open-label extension phase... | Download Scientific Diagram
Open-Label Extension Studies | SpringerLink
Spotlight on Open-Label Extension Studies
Epidemiology and Clinical Research Design, Part 1: Study Types. - Abstract - Europe PMC
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Trials | Full Text
ANDES A Phase 4 Randomized Open Label Study
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine
open label - List of Frontiers' open access articles
31 Open Label Study Bias - Labels Design Ideas 2020
Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). | Semantic Scholar
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full
Patient disposition in REGAIN and the open-label study | Download Scientific Diagram
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals
Study Design And Primary/Secondary Endpoints/Results
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology
Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram
